<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">psychiatry</journal-id><journal-title-group><journal-title xml:lang="ru">ПСИХИАТРИЯ</journal-title><trans-title-group xml:lang="en"><trans-title>Psychiatry (Moscow) (Psikhiatriya)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1683-8319</issn><issn pub-type="epub">2618-6667</issn><publisher><publisher-name>FSBSI “The Mental Health Research Centre”;   LLC «Publisher «MIA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2618-6667-2021-19-2-17-28</article-id><article-id custom-type="elpub" pub-id-type="custom">psychiatry-642</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПСИХОПАТОЛОГИЯ, КЛИНИЧЕСКАЯ И БИОЛОГИЧЕСКАЯ ПСИХИАТРИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PSYCHOPATHOLOGY, CLINICAL AND BIOLOGICAL PSYCHIATRY</subject></subj-group></article-categories><title-group><article-title>Клинико-динамические особенности и прогностическое значение некогнитивных психопатологических симптомов при синдроме мягкого когнитивного снижения</article-title><trans-title-group xml:lang="en"><trans-title>Clinical and Dynamic Features and Prognostic Value of Non-Cognitive Psychopathological Symptoms in Mild Cognitive Impairment (MCI)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9536-0329</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сердюк</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Serdyuk</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сердюк Олег Викторович, главный врач</p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Oleg V. Serdyuk, Chief Physician</p><p>Yekaterinburg</p></bio><email xlink:type="simple">ovs1303@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5142-3992</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сиденкова</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Sidenkova</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сиденкова Алена Петровна, доктор медицинских наук, заведующая кафедрой психиатрии, психотерапии и наркологии</p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Alena P. Sidenkova, MD, PhD, Dr. of Sci. (Med.), Head of Psychiatry, Psychotherapy and Narcology Department</p><p>Yekaterinburg</p></bio><email xlink:type="simple">sidenkovs@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6766-8502</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хилюк</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khiliuk</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хилюк Дарья Андреевна, психиатр</p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Daria A. Khiliuk, Psychiatrist</p><p>Yekaterinburg</p></bio><email xlink:type="simple">dianovada@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ СО СОКПБ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sverdlovsk Region “Sverdlovsk Regional Clinical Psychiatric Hospital”</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО УГМУ Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Budgetary Educational Institution of Higher Education “Ural State Medical University of the Ministry of Health of Russia”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2021</year></pub-date><volume>19</volume><issue>2</issue><fpage>17</fpage><lpage>28</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сердюк О.В., Сиденкова А.П., Хилюк Д.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Сердюк О.В., Сиденкова А.П., Хилюк Д.А.</copyright-holder><copyright-holder xml:lang="en">Serdyuk O.V., Sidenkova A.P., Khiliuk D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.journalpsychiatry.com/jour/article/view/642">https://www.journalpsychiatry.com/jour/article/view/642</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование: высокая распространенность додементных когнитивных расстройств, риск конверсии в деменцию, клиническая неоднородность некогнитивных психопатологических симптомов делают актуальным проведение анализа взаимного влияния отдельных компонентов синдрома мягкого когнитивного снижения (mild cognitive impairment, MCI).</p></sec><sec><title>Цель</title><p>Цель: исследовать клинико-динамические особенности психопатологических симптомов при MCI и определить их прогностическое значение.</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы: проведено сравнительное проспективное наблюдательное исследование 264 пациентов пожилого возраста с MCI. В основную группу исследования включены 189 пациентов с синдромом MCI с психопатологическими симптомами, в группу сравнения — 75 человек с синдромом MCI без психопатологических симптомов. Повторные клинико-психопатологические и психометрические (MMSE, MoCA, Neuropsychiatric Inventory) оценки проведены через 12 и 24 месяца.</p></sec><sec><title>Результаты</title><p>Результаты: выявлены различия в структуре и динамике когнитивных показателей у пациентов в зависимости от доминирующих психопатологических симптомов. Пациенты с аффективными расстройствами показали низкие результаты субтестов рисования линий, фонематической беглости, способности к вербальной категоризации (p &lt; 0,05). У этих лиц при повторных измерениях показатели отставленной репродукции, ретенции, абстрактного мышления значимо снижены в сравнении с результатами остальных участников исследования (р &lt; 0,05). У пациентов с психотическими симптомами выявлены самые низкие показатели отставленного воспроизведения, пространственно-зрительных, речевых проб, наличие ложных репродукций как при первоначальной оценке, так и в динамике (p &lt; 0,05). Но способность к счетным операциям, объем внимания, рабочей памяти, параметры «узнавания» у них выше, чем у представителей других психопатологических подгрупп (p &lt; 0,05). Обнаружено, что мягкое когнитивное снижение без психопатологических включений имеет меньшую тенденцию к трансформации в деменцию за двухлетний период наблюдения, чем синдром мягкого когнитивного снижения с психопатологическими симптомами.</p></sec><sec><title>Выводы</title><p>Выводы: структура и динамика когнитивных показателей различна в аффективной, психотической, поведенческой подгруппах пациентов с MCI и отличается от динамики MCI без психопатологических симптомов. Наличие аффективных симптомов ассоциировано с самой высокой скоростью конверсии MCI в деменцию. У пациентов с мягким когнитивным снижением без психопатологических симптомов стабильность когнитивного расстройства встречалась чаще, чем при их наличии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background: high prevalence of pre-dementia cognitive disorders (in particular mild cognitive impairment, MCI) in older people, unfavorable predictive value of MCI with a high risk of conversion to dementia, lack of a unified view of facultative, noncognitive psychopathological symptoms (NPS) in its syndromic structure, their clinical heterogeneity, close relationships with mild cognitive impairment syndrome is actualized by the analysis of the mutual influence of the components of MCI syndromes.</p></sec><sec><title>The aim</title><p>The aim: to investigate clinical and dynamic features and determine the prognostic value of non-cognitive psychopathological symptoms in MCI, including various psychopathological symptoms (affective, psychotic, behavioral disorders).</p></sec><sec><title>Patients and methods</title><p>Patients and methods: a comparative dynamic prospective selective observational study of 264 older patients with MCI was carried out. The main study group included 189 patients with NPS; compared group made up 75 cases with MCI represented only by cognitive impairments. Repeated clinical, psychopathological and psychometric assessments (MMSE, MoCa, NPI) were performed at 12 and 24 months. Results: differences were revealed in the structure and dynamics of cognitive indicators in patients with dominance of affective, psychotic or behavioral symptoms. Patients with affective symptoms showed low scores on subtests of line drawing, phonemic fluency, and ability to verbal categorization (p &lt; 0.05). In these individuals, with repeated measurements, the indices of delayed reproduction, retention, abstract thinking were significantly reduced in comparison with the results of the rest of the study participants (p &lt; 0.05). Patients with psychotic symptoms showed the lowest indices of delayed reproduction, spatial-visual, speech tests, false reproductions both at the initial assessment and in the dynamics of observation (p &lt; 0.05). But their parameters of counting, attention, working memory, “recognition” are higher in them than in representatives of other psychopathological subgroups (p &lt; 0.05). It was found that mild cognitive impairment without psychopathological inclusions has a lower tendency to transform into dementia over a two-year follow-up period than MCI, in the structure of which non-cognitive psychopathological symptoms are present.</p></sec><sec><title>Conclusions</title><p>Conclusions: non-cognitive psychopathological symptoms of MCI are heterogeneous in terms of clinical and dynamic characteristics. The structure and dynamics of cognitive indicators is different in the affective, psychotic, behavioral subgroups of patients with MCI. Individuals with affective pathology had the highest rate of MCI conversion to dementia. In patients with MCI without neuropsychiatric symptoms, a favorable course of cognitive impairment was more common than in patients with MCI with non-cognitive psychopathological symptoms.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мягкое когнитивное снижение</kwd><kwd>додементные когнитивные расстройства</kwd><kwd>некогнитивные психопатологические симптомы</kwd><kwd>прогноз</kwd><kwd>риск деменции</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mild cognitive impairment (MCI)</kwd><kwd>pre-dementia cognitive disorders</kwd><kwd>non-cognitive psychopathological symptoms (NPS)</kwd><kwd>prognosis</kwd><kwd>risk of dementia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилова СИ, Калын ЯБ. Социально-средовые факторы и состояние психического здоровья пожилого населения (клинико-эпидемиологическое исследование). Вестник РАМН. 2002;9:15–20.</mixed-citation><mixed-citation xml:lang="en">Gavrilova SI, Kalyn YаB. Social’no-sredovye faktory i sostoyanie psihicheskogo zdorov’ya pozhilogo naseleniya (kliniko-epidemiologicheskoe issledovanie). Vestnik RAMN. 2002;9:15–20. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилова СИ, Калын ЯБ. Социальные факторы и психические расстройства в пожилом и старческом возрасте. Руководство по социальной психиатрии. Под ред. Т.Б. Дмитриевой, Б.С. Положего. М.: МИА;2009:174–195.</mixed-citation><mixed-citation xml:lang="en">Gavrilova SI, Kalyn YaB. Social’nye faktoryi i psihiche skierasstrojstva v pozhilom I starcheskom vozraste. In: Rukovodstvo po social’noj psihiatrii. Pod red. T.B. Dmitrievoj, B.S. Polozhego. M.: MIA;2009:174–195. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилова СИ, Федорова ЯБ, Рощина ИФ, Коровайцева ГИ. Прогноз синдрома мягкого когнитивного снижения по данным двухлетнего клинико-катамнестического исследования. Журнал неврологии и психиатрии имени С.С. Корсакова. 2007;107(1):4–10.</mixed-citation><mixed-citation xml:lang="en">Gavrilova SI, Fedorova YaB, Roshchina IF, Korovajceva GI. Prognois of syndrome of mild cognitive impairment on data of two years follow-up. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova. 2007;107(1):4–10. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br. J. Psychiatry. 2003;182:449–454. PMID: 12724250</mixed-citation><mixed-citation xml:lang="en">Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br. J. Psychiatry. 2003;182:449–454. PMID: 12724250</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, Höglund K, Andreasson U, Wetterberg H, Börjesson-Hanson A, Blennow K, Skoog I. Prevalence of preclinical Alzheimer disease: Comparison of current classifi cation systems. Neurology. 2018;90(19):e1682–e1691. doi: 10.1212/WNL.0000000000005476. Epub 2018 Apr 13. PMID: 29653987; PMCID: PMC5952969</mixed-citation><mixed-citation xml:lang="en">Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, Höglund K, Andreasson U, Wetterberg H, Börjesson-Hanson A, Blennow K, Skoog I. Prevalence of preclinical Alzheimer disease: Comparison of current classifi cation systems. Neurology. 2018;90(19):e1682–e1691. doi: 10.1212/WNL.0000000000005476. Epub 2018 Apr 13. PMID: 29653987; PMCID: PMC5952969</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer K, Bäckman L, Winblad B, Fratiglioni L. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am. J. Geriatr. Psychiatry. 2008;16(7):603–611. doi: 10.1097/JGP.0b013e3181753a64. PMID: 18591580</mixed-citation><mixed-citation xml:lang="en">Palmer K, Bäckman L, Winblad B, Fratiglioni L. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease. Am. J. Geriatr. Psychiatry. 2008;16(7):603–611. doi: 10.1097/JGP.0b013e3181753a64. PMID: 18591580</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classifi cation of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch. Neurol. 2003;60(10):1385–1389. doi: 10.1001/archneur.60.10.1385. PMID: 14568808</mixed-citation><mixed-citation xml:lang="en">Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatrick A, Dulberg C, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH. Prevalence and classifi cation of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch. Neurol. 2003;60(10):1385–1389. doi: 10.1001/archneur.60.10.1385. PMID: 14568808</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann. Neurol. 2008;63(4):494–506. doi: 10.1002/ana.21326. PMID: 18300306; PMCID: PMC2375143</mixed-citation><mixed-citation xml:lang="en">Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann. Neurol. 2008;63(4):494–506. doi: 10.1002/ana.21326. PMID: 18300306; PMCID: PMC2375143</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ерназарова ЖШ, Асылбек А, Ешманова АК, Игисенова А, Умутбаева ГБ, Абикулова АК, Аканова АА, Маншарипова АТ, Молдабек ГК, Толеуова ДЖ, Белтенова АГ, Бейсенай УК. Определение потребности пациентов пожилого и старческого возраста в медико-социальной и психологической помощи. Medicine (Almaty). 2016;11(173):81–86.</mixed-citation><mixed-citation xml:lang="en">Ernazarova ZhSh, Asylbek A, Eshmanova AK, Igisenova A, Umutbaeva GB, Abikulova AK, Akanova AA, Mansharipova AT, Moldabek GK, Toleuova DZh, Beltenova AG, Bejsenaj UK. Opredelenie potrebnosti pacientov pozhilogo I starcheskogo vozrasta v mediko-social’noj I psihologicheskoj pomoshchi. Medicine (Almaty). 2016;11(173):81–86. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Захаров ВВ. Дофаминергическая и норадренергическая терапия когнитивных нарушений. Журнал неврологии и психиатрии имени С.С. Корсакова. 2006;106(9):43–47.</mixed-citation><mixed-citation xml:lang="en">Zaharov VV. Dofaminergic and noradrenergic therapy of cognitive disorders. Zhurnal nevrologii i psihiatriiim imeni S.S. Korsakova. 2006;106(9):43–47. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–135. doi: 10.1212/WNL.0000000000004826. PMID: 29282327; PMCID: PMC5772157</mixed-citation><mixed-citation xml:lang="en">Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–135. doi: 10.1212/WNL.0000000000004826. PMID: 29282327; PMCID: PMC5772157</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Huey ED, Manly JJ, Tang MX, Schupf N, Brickman AM, Manoochehri M, Mez J, DeCarli C, Devanand DP, Mayeux R. Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement. 2013; 9(6):632–639. doi: 10.1016/j.jalz.2012.10.014. PMID: 23452959; PMCID: PMC3933297</mixed-citation><mixed-citation xml:lang="en">Huey ED, Manly JJ, Tang MX, Schupf N, Brickman AM, Manoochehri M, Mez J, DeCarli C, Devanand DP, Mayeux R. Course and etiology of dysexecutive MCI in a community sample. Alzheimers Dement. 2013; 9(6):632–639. doi: 10.1016/j.jalz.2012.10.014. PMID: 23452959; PMCID: PMC3933297</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, Feng J. (11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst. Rev. 2014;2014(7):CD010386. doi: 10.1002/14651858.CD010386.pub2. PMID: 25052054; PMCID: PMC6464750</mixed-citation><mixed-citation xml:lang="en">Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, Feng J. (11)C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst. Rev. 2014;2014(7):CD010386. doi: 10.1002/14651858.CD010386.pub2. PMID: 25052054; PMCID: PMC6464750</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB. Prevalence of cognitive impairment without dementia in the United States. Ann. Intern. Med. 2008;148(6):427–434. doi: 10.7326/0003-4819-148-6-200803180-00005. Erratum in: Ann. Intern. Med. 2009;151(4):291–292. PMID: 18347351; PMCID: PMC2670458</mixed-citation><mixed-citation xml:lang="en">Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB. Prevalence of cognitive impairment without dementia in the United States. Ann. Intern. Med. 2008;148(6):427–434. doi: 10.7326/0003-4819-148-6-200803180-00005. Erratum in: Ann. Intern. Med. 2009;151(4):291–292. PMID: 18347351; PMCID: PMC2670458</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Aerts L, Heffernan M, Kochan NA, Crawford JD, Draper B, Trollor JN, Sachdev PS, Brodaty H. Effects of MCI subtype and reversion on progression to dementia in a community sample. Neurology. 2017;88(23):2225–2232. doi: 10.1212/WNL.000000000000401</mixed-citation><mixed-citation xml:lang="en">Aerts L, Heffernan M, Kochan NA, Crawford JD, Draper B, Trollor JN, Sachdev PS, Brodaty H. Effects of MCI subtype and reversion on progression to dementia in a community sample. Neurology. 2017;88(23):2225–2232. doi: 10.1212/WNL.000000000000401</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA, Petersen RC. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014;82(4):317–325. doi: 10.1212/WNL.0000000000000055</mixed-citation><mixed-citation xml:lang="en">Roberts RO, Knopman DS, Mielke MM, Cha RH, Pankratz VS, Christianson TJ, Geda YE, Boeve BF, Ivnik RJ, Tangalos EG, Rocca WA, Petersen RC. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014;82(4):317–325. doi: 10.1212/WNL.0000000000000055</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Гаврилова СИ. Додементные нейрокогнитивные расстройства: диагностические и терапевтические аспекты. Обозрение психиатрии и медицинской психологии. 2018;1:89–98.</mixed-citation><mixed-citation xml:lang="en">Gavr ilova SI. Dodementnye nejrokognitivnye rasstrojstva: diagnosticheskie i terapevticheskie aspekty. Obozrenie psihiatrii i medicinskoj psihologii. 2018;1:89–98. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J. Alzheimers Dis. 2009;18(1):11–30. doi: 10.3233/JAD-2009-1120. PMID: 19542627</mixed-citation><mixed-citation xml:lang="en">Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J. Alzheimers Dis. 2009;18(1):11–30. doi: 10.3233/JAD-2009-1120. PMID: 19542627</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez OL, Becker JT, Sweet RA. Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase. 2005;11(1):65–71. doi: 10.1080/13554790490896893. PMID: 15804926</mixed-citation><mixed-citation xml:lang="en">Lopez OL, Becker JT, Sweet RA. Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase. 2005;11(1):65–71. doi: 10.1080/13554790490896893. PMID: 15804926</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors. NIA-AA Research Framework: Toward a biological defi nition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562. doi: 10.1016/j.jalz.2018.02.018. PMID: 29653606; PMCID: PMC5958625</mixed-citation><mixed-citation xml:lang="en">Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R; Contributors. NIA-AA Research Framework: Toward a biological defi nition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–562. doi: 10.1016/j.jalz.2018.02.018. PMID: 29653606; PMCID: PMC5958625</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Peters ME, Rosenberg PB, Steinberg M, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner J, Tschanz JT, Lyketsos CG; Cache County Investigators. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am. J. Geriatr. Psychiatry. 2013;21(11):1116–1124. doi: 10.1016/j.jagp.2013.01.049. PMID: 23567370; PMCID: PMC3525756</mixed-citation><mixed-citation xml:lang="en">Peters ME, Rosenberg PB, Steinberg M, Norton MC, Welsh-Bohmer KA, Hayden KM, Breitner J, Tschanz JT, Lyketsos CG; Cache County Investigators. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. Am. J. Geriatr. Psychiatry. 2013;21(11):1116–1124. doi: 10.1016/j.jagp.2013.01.049. PMID: 23567370; PMCID: PMC3525756</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Liew TM. Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons. J. Am. Med. Dir. Assoc. 2019;20(8):1054.e1 — 1054.e9. doi: 10.1016/j.jamda.2019.02.012. Epub 2019 Mar 26. PMID: 30926409; PMCID: PMC6663577</mixed-citation><mixed-citation xml:lang="en">Liew TM. Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons. J. Am. Med. Dir. Assoc. 2019;20(8):1054.e1 — 1054.e9. doi: 10.1016/j.jamda.2019.02.012. Epub 2019 Mar 26. PMID: 30926409; PMCID: PMC6663577</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alzheimers Res. Ther. 2020;12(1):35. doi: 10.1186/s13195-020-00604-7. PMID: 32234066; PMCID: PMC7110750</mixed-citation><mixed-citation xml:lang="en">Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alzheimers Res. Ther. 2020;12(1):35. doi: 10.1186/s13195-020-00604-7. PMID: 32234066; PMCID: PMC7110750</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Volkert J, Schulz H, Härter M, Wlodarczyk O, Andreas S. The prevalence of mental disorders in older people in Western countries — a meta-analysis. Ageing Res. Rev. 2013;12(1):339–353. doi: 10.1016/j.arr.2012.09.004. PMID: 23000171</mixed-citation><mixed-citation xml:lang="en">Volkert J, Schulz H, Härter M, Wlodarczyk O, Andreas S. The prevalence of mental disorders in older people in Western countries — a meta-analysis. Ageing Res. Rev. 2013;12(1):339–353. doi: 10.1016/j.arr.2012.09.004. PMID: 23000171</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Гантман МВ. Выявление деменции на амбулаторном приеме пожилых. Современная терапия в психиатрии и неврологии. 2016;3:4–8.</mixed-citation><mixed-citation xml:lang="en">Gantman MV. Vyyavlenie demencii na ambulatornom prieme pozhilyh. Sovremennaya terapiya v psihiatrii i nevrologii. 2016;3:4–8. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Сафарова ТП. Депрессивные расстройства в позднем возрасте: особенности клиники и течения. Психиатрия. 2019;17(3):87–97.</mixed-citation><mixed-citation xml:lang="en">Safarova TP. Depressive disorders in old age: clinical features and course. Psychiatry (Moscow) (Psikhiatriya). 2019;17(3):87–97. (In Russ.). doi: 10.30629/2618-6667-2019-17-3-87-97</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Селезнева НД, Пономарева ЕВ. Депрессивные расстройства в структуре деменции, обусловленной болезнью Альцгеймера: корреляции с динамикой когнитивного дефицита Сборник научных материалов симпозиума «Современное состояние исследований, диагностика и терапия нейродегенеративных заболеваний». Москва, 17–18 ноября 2005 г. Институт биохимической физики им. Н.М. Эммануэля РАН:15–22.</mixed-citation><mixed-citation xml:lang="en">Selezneva ND, Ponomareva EV. Depressivnye rasstrojstva v strukture demencij, obuslovlennoj bolezn’yu Al’cgejmera: korrelyacii s dinamikoj kognitivnogo deficita Sbornik nauchnyh materialov simpoziuma «Sovremennoe sostoyanie issledovanij, diagnostika i terapiya nejrodegenerativnyh zabolevanij». Moskva, 17–18 noyabrya 2005 g. Institut biohimicheskoj fiziki im. N.M. Emmanuelya RAN:15–22. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Pandya SY, Clem MA, Silva LM, Woon FL. Does mild cognitive impairment always lead to dementia? A review. J. Neurol. Sci. 2016;369:57–62. doi: 10.1016/j.jns.2016.07.055. Epub 2016 Jul 26. PMID: 27653867</mixed-citation><mixed-citation xml:lang="en">Pandya SY, Clem MA, Silva LM, Woon FL. Does mild cognitive impairment always lead to dementia? A review. J. Neurol. Sci. 2016;369:57–62. doi: 10.1016/j.jns.2016.07.055. Epub 2016 Jul 26. PMID: 27653867</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Xu J, Li Q, Qin W, Jun Li M, Zhuo C, Liu H, Liu F, Wang J, Schumann G, Yu C. Neurobiological substrates underlying the effect of genomic risk for depression on the conversion of amnestic mild cognitive impairment. Brain. 2018;141(12):3457–3471. doi: 10.1093/brain/awy277. PMID: 30445590; PMCID: PMC6693294</mixed-citation><mixed-citation xml:lang="en">Xu J, Li Q, Qin W, Jun Li M, Zhuo C, Liu H, Liu F, Wang J, Schumann G, Yu C. Neurobiological substrates underlying the effect of genomic risk for depression on the conversion of amnestic mild cognitive impairment. Brain. 2018;141(12):3457–3471. doi: 10.1093/brain/awy277. PMID: 30445590; PMCID: PMC6693294</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, Lyketsos ConstantineG. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study. Am. J. Psychiatry. 2015;172(5):460–465. doi: 10.1176/appi.ajp.2014.14040480</mixed-citation><mixed-citation xml:lang="en">Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, Lyketsos ConstantineG. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study Neuropsychiatric symptoms as predictors of progression to severe Alzheimer’s dementia and death: the Cache County Dementia Progression Study. Am. J. Psychiatry. 2015;172(5):460–465. doi: 10.1176/appi.ajp.2014.14040480</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Siafarikas N, Selbaek G, Fladby T, Šaltytė Benth J, Auning E, Aarsland D. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer’s disease. Int. Psychogeriatr. 2018;30(1):103–113. doi:10.1017/S1041610217001879</mixed-citation><mixed-citation xml:lang="en">Siafarikas N, Selbaek G, Fladby T, Šaltytė Benth J, Auning E, Aarsland D. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer’s disease. Int. Psychogeriatr. 2018;30(1):103–113. doi:10.1017/S1041610217001879</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Сиденкова АП. Особенности проявления тревоги у пациентов старших возрастных групп с разными типами умеренного когнитивного расстройства. Журнал неврологии и психиатрии имени С.С. Корсакова. 2017;117(11):45–50. doi: 10.17116/jnevro201711711145-50</mixed-citation><mixed-citation xml:lang="en">Sidenkova AP. Characteristics of anxiety in patients of older age groups with different types of mild cognitive disorder. S.S. Korsakov Journal of neurology and psychiatry. 2017;117(11):45–50. (In Russ.). 10.17116/jnevro201711711145-50</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Taragano FE, Allegri RF, Krupitzki H, Sarasola DR, Serrano CM, Loñ L, Lyketsos CG. Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J. Clin. Psychiatry. 2009;70(4):584–592. doi: 10.4088/jcp.08m04181. Epub 2009 Mar 24. PMID: 19323967; PMCID: PMC2711522</mixed-citation><mixed-citation xml:lang="en">Taragano FE, Allegri RF, Krupitzki H, Sarasola DR, Serrano CM, Loñ L, Lyketsos CG. Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J. Clin. Psychiatry. 2009;70(4):584–592. doi: 10.4088/jcp.08m04181. Epub 2009 Mar 24. PMID: 19323967; PMCID: PMC2711522</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Geda YE, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Sochor O, Tangalos EG, Petersen RC, Rocca WA. Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. Am. J. Psychiatry. 2014;171(5):572–581. doi: 10.1176/appi.ajp.2014.13060821. PMID: 24700290; PMCID: PMC4057095</mixed-citation><mixed-citation xml:lang="en">Geda YE, Roberts RO, Mielke MM, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Sochor O, Tangalos EG, Petersen RC, Rocca WA. Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. Am. J. Psychiatry. 2014;171(5):572–581. doi: 10.1176/appi.ajp.2014.13060821. PMID: 24700290; PMCID: PMC4057095</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alzheimers Res. Ther. 2020;12(1):35. doi: 10.1186/s13195-020-00604-7. PMID: 32234066; PMCID: PMC7110750</mixed-citation><mixed-citation xml:lang="en">Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia. Alzheimers Res. Ther. 2020;12(1):35. doi: 10.1186/s13195-020-00604-7. PMID: 32234066; PMCID: PMC7110750</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Tagariello P, Girardi P, Amore M. Depression and apathy in dementia: same syndrome or different constructs? A critical review. Arch. Gerontol. Geriatr. 2009;49(2):246–249. doi: 10.1016/j.archger.2008.09.002. PMID: 19022508</mixed-citation><mixed-citation xml:lang="en">Tagariello P, Girardi P, Amore M. Depression and apathy in dementia: same syndrome or different constructs? A critical review. Arch. Gerontol. Geriatr. 2009;49(2):246–249. doi: 10.1016/j.archger.2008.09.002. PMID: 19022508</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, Tzourio C, Rouaud O, Poncet M, Pasquier F, Aur iacombe S, Touchon J, Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specif ic. J. Neurol. Neurosurg. Psychiatry. 2008;79(9):979–984. doi: 10.1136/jnnp.2007.136903. PMID: 18450788</mixed-citation><mixed-citation xml:lang="en">Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, Tzourio C, Rouaud O, Poncet M, Pasquier F, Aur iacombe S, Touchon J, Ritchie K. Risk profiles for mild cognitive impairment and progression to dementia are gender specif ic. J. Neurol. Neurosurg. Psychiatry. 2008;79(9):979–984. doi: 10.1136/jnnp.2007.136903. PMID: 18450788</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Golomb J, Kluger A, Garrard P, Ferris S. Clinician’s manual on mild cognitive impairment. London: Science Press Ltd., 2001:56.</mixed-citation><mixed-citation xml:lang="en">Golomb J, Kluger A, Garrard P, Ferris S. Clinician’s manual on mild cognitive impairment. London: Science Press Ltd., 2001:56.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189–198. doi: 10.1016/0022-3956 (75)90026-6. PMID: 1202204</mixed-citation><mixed-citation xml:lang="en">Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189–198. doi: 10.1016/0022-3956 (75)90026-6. PMID: 1202204</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 1982;139(9):1136–1139. doi: 10.1176/ajp.139.9.1136</mixed-citation><mixed-citation xml:lang="en">Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiatry. 1982;139(9):1136–1139. doi: 10.1176/ajp.139.9.1136</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414. doi: 10.1212/wnl.43.11.2412-a. PMID: 8232972</mixed-citation><mixed-citation xml:lang="en">Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–2414. doi: 10.1212/wnl.43.11.2412-a. PMID: 8232972</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am. J. Geriatric. Psychiatry. 2013;21(7):685–695. doi: 10.1016/j.jagp.2013.01.006</mixed-citation><mixed-citation xml:lang="en">Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am. J. Geriatric. Psychiatry. 2013;21(7):685–695. doi: 10.1016/j.jagp.2013.01.006</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer CE, Ismail Z, Youakim JM, Creese B, Kumar S, Nuñez N, Ryan Darby R, Di Vita A, D’Antonio F, de Lena C, McGeown WJ, Ramit R, Rasmussen J, Bell J, Wang H, Bruneau MA, Panegyres PK, Lanctôt KL, Agüera-Ortiz L, Lyketsos C, Cummings J, Jeste DV, Sano M, Devanand DP, Sweet RA, Ballard C. Revisiting criteria for psychosis in Alzheimer’s disease and related dementias: toward better phenotypic classifi cation and biomarker research. J. Alzheimers Dis. 2020;73(3):1143–1156. doi: 10.3233/JAD-190828</mixed-citation><mixed-citation xml:lang="en">Fischer CE, Ismail Z, Youakim JM, Creese B, Kumar S, Nuñez N, Ryan Darby R, Di Vita A, D’Antonio F, de Lena C, McGeown WJ, Ramit R, Rasmussen J, Bell J, Wang H, Bruneau MA, Panegyres PK, Lanctôt KL, Agüera-Ortiz L, Lyketsos C, Cummings J, Jeste DV, Sano M, Devanand DP, Sweet RA, Ballard C. Revisiting criteria for psychosis in Alzheimer’s disease and related dementias: toward better phenotypic classifi cation and biomarker research. J. Alzheimers Dis. 2020;73(3):1143–1156. doi: 10.3233/JAD-190828</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG; ISTAART Neuropsychiatric Symptoms Professional Interest Area. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195–202. doi: 10.1016/j.jalz.2015.05.017. PMID: 26096665; PMCID: PMC4684483</mixed-citation><mixed-citation xml:lang="en">Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, Agüera-Ortiz L, Sweet R, Miller D, Lyketsos CG; ISTAART Neuropsychiatric Symptoms Professional Interest Area. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195–202. doi: 10.1016/j.jalz.2015.05.017. PMID: 26096665; PMCID: PMC4684483</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
